Try our beta test site
1 study found for:    14534339 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Nilotinib as First-line Treatment of Ph+ CML in Early Chronic Phase
Condition: Chronic Myeloid Leukemia
Intervention: Drug: Nilotinib

Study has passed its completion date and status has not been verified in more than two years.